Page last updated: 2024-09-03

ro 8-0576 and Hyperactivity, Motor

ro 8-0576 has been researched along with Hyperactivity, Motor in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Begemann, M; Damen, R; Elbracht, M; Häusler, M; Knopp, C; Kurth, I; Mull, M; Müller, B; Stoppe, A1
Alachkar, A; Brotchie, JM; Jones, OT1
Inoue, T; Koyama, M; Ogata, A; Tani, Y1
Gerlach, J1

Trials

1 trial(s) available for ro 8-0576 and Hyperactivity, Motor

ArticleYear
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial.
    Acta neurologica Scandinavica, 1976, Volume: 53, Issue:3

    Topics: Aged; Azides; Benserazide; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Ergolines; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychoses, Substance-Induced

1976

Other Studies

3 other study(ies) available for ro 8-0576 and Hyperactivity, Motor

ArticleYear
PDE10A mutation in two sisters with a hyperkinetic movement disorder - Response to levodopa.
    Parkinsonism & related disorders, 2019, Volume: 63

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Child; Consanguinity; Dopamine Agents; Drug Combinations; Epilepsy, Temporal Lobe; Exome Sequencing; Female; Humans; Hyperkinesis; Infant; Levodopa; Movement Disorders; Phosphoric Diester Hydrolases; Siblings

2019
Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
    Neuroscience research, 2010, Volume: 68, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Brain Chemistry; Disease Models, Animal; Dopamine Agents; Drug Combinations; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Hydrazines; Hyperkinesis; Levodopa; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Reserpine; Serotonin Receptor Agonists

2010
Effects of piclozotan (SUN N4057), a partial serotonin 1A receptor agonist, on motor complications induced by repeated administration of levodopa in parkinsonian rats.
    European journal of pharmacology, 2010, Dec-15, Volume: 649, Issue:1-3

    Topics: Animals; Antiparkinson Agents; Behavior, Animal; Benserazide; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Partial Agonism; Dyskinesia, Drug-Induced; Hyperkinesis; Levodopa; Male; Microdialysis; Motor Activity; Oxazepines; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists

2010